A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate the Analgesic Efficacy and Safety of Intravenous CR845 During the Post-Operative Period in Subjects Undergoing Laparoscopic-Assisted Hysterectomy

Trial Profile

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate the Analgesic Efficacy and Safety of Intravenous CR845 During the Post-Operative Period in Subjects Undergoing Laparoscopic-Assisted Hysterectomy

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Mar 2016

At a glance

  • Drugs Difelikefalin (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Cara Therapeutics
  • Most Recent Events

    • 10 Mar 2016 According to a Cara Therapeutics media release, data from this study were presented at the American Society of Health-System Pharmacists (ASHP) 2015 Midyear Clinical Meeting.
    • 01 Dec 2015 Postoperative nausea and vomiting results will be presented at the American Society of Health-System Pharmacists (ASHP) 2015 Midyear Clinical Meeting, according to a Cara Therapeutics media release.
    • 19 Oct 2015 According to a Cara Therapeutics media release, data from this study will be presented at the American Society of Anesthesiologists' annual meeting 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top